POY_1170x120_8-12-19

Cold-EEZE

Mylan grows in OTCs with Cold-EEZE acquisition

Mylan grows in OTCs with Cold-EEZE acquisition

PITTSBURGH — Furthering its expansion in the consumer health care arena, Mylan has closed its acquisition of the Cold-EEZE over-the-counter cold remedy line from ProPhase Labs Inc. The transaction, announced in January, gives Mylan all global rights and assets relating to the Cold-EEZE brand, including all U.S. businesses and U.S. and international trademarks. Cold-EEZE’s broad

Mylan to acquire Cold-EEZE

Mylan to acquire Cold-EEZE

PITTSBURGH — Mylan N.V. plans to acquire the global rights to the Cold-EEZE over-the-counter cold remedy brand from ProPhase Labs Inc. Under the agreement, Mylan’s U.S. OTC subsidiary will buy substantially all of the assets and other rights relating to the Cold-EEZE brand. Financial terms weren’t disclosed. Cold-EEZE products sold in the U.S. market include